BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31588566)

  • 21. IgM paraproteinaemia: disease associations and laboratory features.
    Roberts-Thomson PJ; Nikoloutsopoulos T; Smith AJ
    Pathology; 2002 Aug; 34(4):356-61. PubMed ID: 12190295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropathy and monoclonal gammopathy.
    Nobile-Orazio E
    Handb Clin Neurol; 2013; 115():443-59. PubMed ID: 23931795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological correlates of IgM paraproteinemias.
    Owen RG; Parapia LA; Higginson J; Misbah SA; Child JA; Morgan GJ; Jack AS
    Clin Lymphoma; 2000 Jun; 1(1):39-43; discussion 44-5. PubMed ID: 11707811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
    Treon SP; Shima Y; Preffer FI; Doss DS; Ellman L; Schlossman RL; Grossbard ML; Belch AR; Pilarski LM; Anderson KC
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):97-106. PubMed ID: 10561024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature.
    Gomez A; Hoffman JE
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):e101-8. PubMed ID: 27245314
    [No Abstract]   [Full Text] [Related]  

  • 26. Monoclonal gammopathy and neuropathy.
    Ramchandren S; Lewis RA
    Curr Opin Neurol; 2009 Oct; 22(5):480-5. PubMed ID: 19625962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab treatment provides no clinical benefit in patients with pretreated advanced multiple myeloma.
    Zojer N; Kirchbacher K; Vesely M; Hübl W; Ludwig H
    Leuk Lymphoma; 2006 Jun; 47(6):1103-9. PubMed ID: 16840202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peripheral neuropathy with monoclonal gammopathy].
    Meier T; Meyer M
    Schweiz Med Wochenschr; 1990 Mar; 120(12):417-25. PubMed ID: 2157280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe motor-dominant neuropathy with IgM M-protein binding to the NeuAcalpha2-3Galbeta- moiety.
    Oga T; Kusunoki S; Fujimura H; Kuboki T; Yoshida T; Takai T
    J Neurol Sci; 1998 Jan; 154(1):4-7. PubMed ID: 9543315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute inflammatory neuropathy with monoclonal anti-GM2 IgM antibodies, IgM-κ paraprotein and additional autoimmune processes in association with a diffuse large B-cell non-Hodgkin's lymphoma.
    Milnik A; Roggenbuck D; Conrad K; Bartels C
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23341581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-grade B-cell cerebral lymphoma in a patient with anti-myelin-associated glycoprotein IgM paraproteinemic neuropathy.
    Ellie E; Vital A; Steck AJ; Julien J; Henry P; Vital C
    Neurology; 1995 Feb; 45(2):378-81. PubMed ID: 7531825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Peripheral neuropathies associated with IgM monoclonal gammopathy: clinical and electrophysiological aspects].
    Léger JM; Chassande B; Bouche P
    Rev Neurol (Paris); 1996 May; 152(5):394-9. PubMed ID: 8881438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab treatment of an IgM monoclonal autonomic and sensory neuropathy.
    Goldfarb AR; Weimer LH; Brannagan TH
    Muscle Nerve; 2005 Apr; 31(4):510-5. PubMed ID: 15685616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).
    Kvarnstrom M; Sidorova E; Nilsson J; Ekerfelt C; Vrethem M; Soderberg O; Johansson M; Rosen A; Ernerudh J
    Clin Exp Immunol; 2002 Feb; 127(2):255-62. PubMed ID: 11876747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow.
    Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E
    Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraproteinemic neuropathy.
    Zivković SA; Lacomis D; Lentzsch S
    Leuk Lymphoma; 2009 Sep; 50(9):1422-33. PubMed ID: 19637090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein.
    Yin CC; Lin P; Carney DA; Handy BC; Rassidakis GZ; Admirand JH; Keating MJ; Medeiros LJ
    Am J Clin Pathol; 2005 Apr; 123(4):594-602. PubMed ID: 15743747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A monoclonal protein identified by an anomalous lipaemia index.
    Monk C; Wallage M; Wassell J; Whiteway A; James J; Beetham R
    Ann Clin Biochem; 2009 May; 46(Pt 3):250-2. PubMed ID: 19261678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. t(11;18)(q21;q21)-positive advanced-stage MALT lymphoma associated with monoclonal gammopathy: resistance to rituximab or rituximab-containing chemotherapy.
    Ohno H; Isoda K
    J Clin Exp Hematop; 2008 Nov; 48(2):47-54. PubMed ID: 19039196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.
    Latov N
    Ann Neurol; 1995 May; 37 Suppl 1():S32-42. PubMed ID: 8968215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.